Marcel V. Alavi

2.2k total citations
25 papers, 1.2k citations indexed

About

Marcel V. Alavi is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Clinical Biochemistry. According to data from OpenAlex, Marcel V. Alavi has authored 25 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 3 papers in Cellular and Molecular Neuroscience and 3 papers in Clinical Biochemistry. Recurrent topics in Marcel V. Alavi's work include Mitochondrial Function and Pathology (14 papers), ATP Synthase and ATPases Research (10 papers) and Retinal Development and Disorders (6 papers). Marcel V. Alavi is often cited by papers focused on Mitochondrial Function and Pathology (14 papers), ATP Synthase and ATPases Research (10 papers) and Retinal Development and Disorders (6 papers). Marcel V. Alavi collaborates with scholars based in Germany, United States and France. Marcel V. Alavi's co-authors include Nico Fuhrmann, Bernd Wissinger, Ulrich Schraermeyer, Simone Schimpf, Jürgen Laufs, Hans F. Wehrl, Stefanie Bette, Robert N. Weinreb, Duc T. Nguyen and KY Kim and has published in prestigious journals such as Journal of Biological Chemistry, Brain and The Journal of Physiology.

In The Last Decade

Marcel V. Alavi

25 papers receiving 1.2k citations

Peers

Marcel V. Alavi

CMN

PHYSI

OPHTH

Małgorzata Piechota Poland

Sébastien Augustin France

Bernard Arnaud France

Judy V. Nguyen United States

Claire‐Marie Dhaenens France

J. Arjuna Ratnayaka United Kingdom

Keiichi Komeima Japan

Yasunari Munemasa Japan

Maki Kayama Japan

Laura Campello Spain

Małgorzata Piechota Poland

Marcel V. Alavi

701 ×0.7

173 ×1.0

81 ×0.5

CMN

208 ×1.3

PHYSI

111 ×0.8

OPHTH

Citations per year, relative to Marcel V. Alavi Marcel V. Alavi (= 1×) peers Małgorzata Piechota

Countries citing papers authored by Marcel V. Alavi

Since Specialization

Citations

This map shows the geographic impact of Marcel V. Alavi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcel V. Alavi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcel V. Alavi more than expected).

Fields of papers citing papers by Marcel V. Alavi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcel V. Alavi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcel V. Alavi. The network helps show where Marcel V. Alavi may publish in the future.

Co-authorship network of co-authors of Marcel V. Alavi

This figure shows the co-authorship network connecting the top 25 collaborators of Marcel V. Alavi. A scholar is included among the top collaborators of Marcel V. Alavi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcel V. Alavi. Marcel V. Alavi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alavi, Marcel V.. (2022). Recent advances in, and challenges of, designing OMA1 drug screens. Pharmacological Research. 176. 106063–106063. 7 indexed citations

Alavi, Marcel V.. (2021). Tau phosphorylation and OPA1 proteolysis are unrelated events: Implications for Alzheimer's Disease. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1868(12). 119116–119116. 4 indexed citations

Alavi, Marcel V.. (2021). OMA1 High-Throughput Screen Reveals Protease Activation by Kinase Inhibitors. ACS Chemical Biology. 16(11). 2202–2211. 4 indexed citations

Alavi, Marcel V.. (2020). OMA1—An integral membrane protease?. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1869(2). 140558–140558. 16 indexed citations

Roddy, Gavin W., Douglas Yasumura, Michael T. Matthes, et al.. (2017). Long-term photoreceptor rescue in two rodent models of retinitis pigmentosa by adeno-associated virus delivery of Stanniocalcin-1. Experimental Eye Research. 165. 175–181. 13 indexed citations

Alavi, Marcel V., Mao Mao, Bradley Pawlikowski, et al.. (2016). Col4a1 mutations cause progressive retinal neovascular defects and retinopathy. Scientific Reports. 6(1). 18602–18602. 31 indexed citations

Alavi, Marcel V.. (2015). Aging and Vision. Advances in experimental medicine and biology. 854. 393–399. 11 indexed citations

Alavi, Marcel V. & Nico Fuhrmann. (2013). Dominant optic atrophy, OPA1, and mitochondrial quality control: understanding mitochondrial network dynamics. Molecular Neurodegeneration. 8(1). 32–32. 106 indexed citations

Caffin, Fanny, Alexandre Prola, Jérôme Piquereau, et al.. (2013). Altered skeletal muscle mitochondrial biogenesis but improved endurance capacity in trained OPA1‐deficient mice. The Journal of Physiology. 591(23). 6017–6037. 37 indexed citations

10.

Piquereau, Jérôme, Fanny Caffin, Marta Novotová, et al.. (2012). Down-regulation of OPA1 alters mouse mitochondrial morphology, PTP function, and cardiac adaptation to pressure overload. Cardiovascular Research. 94(3). 408–417. 149 indexed citations

11.

Nguyen, Duc T., Marcel V. Alavi, KY Kim, et al.. (2011). A new vicious cycle involving glutamate excitotoxicity, oxidative stress and mitochondrial dynamics. Cell Death and Disease. 2(12). e240–e240. 179 indexed citations

12.

Fuhrmann, Nico, Simone Schimpf, York Kamenisch, et al.. (2010). Solving a 50 year mystery of a missing OPA1 mutation: more insights from the first family diagnosed with autosomal dominant optic atrophy. Molecular Neurodegeneration. 5(1). 25–25. 15 indexed citations

13.

Sancho-Pellúz, Javier, Marcel V. Alavi, Ayse Sahaboglu, et al.. (2010). Excessive HDAC activation is critical for neurodegeneration in the rd1 mouse. Cell Death and Disease. 1(2). e24–e24. 102 indexed citations

14.

Heiduschka, Peter, Sven Schnichels, Nico Fuhrmann, et al.. (2010). Electrophysiological and Histologic Assessment of Retinal Ganglion Cell Fate in a Mouse Model forOPA1-Associated Autosomal Dominant Optic Atrophy. Investigative Ophthalmology & Visual Science. 51(3). 1424–1424. 55 indexed citations

15.

Alavi, Marcel V., Nico Fuhrmann, Huu Phuc Nguyen, et al.. (2009). Subtle neurological and metabolic abnormalities in an Opa1 mouse model of autosomal dominant optic atrophy. Experimental Neurology. 220(2). 404–409. 39 indexed citations

16.

Fuhrmann, Nico, Marcel V. Alavi, Pierre Bitoun, et al.. (2009). Genomic rearrangements in OPA1 are frequent in patients with autosomal dominant optic atrophy. Journal of Medical Genetics. 46(2). 136–144. 42 indexed citations

17.

Weisschuh, Nicole, Marcel V. Alavi, Michael Bonin, & Bernd Wissinger. (2007). Identification of genes that are linked with optineurin expression using a combined RNAi–microarray approach. Experimental Eye Research. 85(4). 450–461. 15 indexed citations

18.

Alavi, Marcel V., Stefanie Bette, Simone Schimpf, et al.. (2006). A splice site mutation in the murine Opa1 gene features pathology of autosomal dominant optic atrophy. Brain. 130(4). 1029–1042. 207 indexed citations

19.

Alavi, Marcel V. & Enrico Schleiff. (2005). Analysis of expression patterns of translocon subunits of chloroplasts and mitochondria. Plant Science. 168(6). 1533–1539. 4 indexed citations

20.

Vojta, Aleksandar, Marcel V. Alavi, Thomas Becker, et al.. (2004). The Protein Translocon of the Plastid Envelopes. Journal of Biological Chemistry. 279(20). 21401–21405. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact